• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by Alset Capital Acquisition Corp.

    10/31/23 9:27:11 AM ET
    $ACAX
    Other Pharmaceuticals
    Health Care
    Get the next $ACAX alert in real time by email
    DEFA14A 1 formdefa14a.htm

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 14A

     

    Proxy Statement Pursuant to Section 14(a)

    of the Securities Exchange Act of 1934

     

    Filed by the Registrant ☒

     

    Filed by a Party other than the Registrant ☐

     

    Check the appropriate box:

     

    ☐ Preliminary Proxy Statement
       
    ☐ Confidential, for the use of the Commission only (as permitted by Rule 14a-6(e)(2))
       
    ☐ Definitive Proxy Statement
       
    ☒ Definitive Additional Materials
       
    ☐ Soliciting Material Pursuant to §240.14a-12

     

    ALSET CAPITAL ACQUISITION CORP.

    (Name of Registrant as Specified in its Charter)

     

     

    (Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)

     

    Payment of Filing Fee (Check the appropriate box):

     

    ☒ No fee required.
       
    ☐ Fee paid previously with preliminary materials.
       
    ☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

     

     

     

     
     

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    Form 8-K

     

    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     

    October 31, 2023

    Date of Report (Date of earliest event reported)

     

    ALSET CAPITAL ACQUISITION CORP.

     

    (Exact Name of Registrant as Specified in its Charter)

     

    Delaware   001-41254   87-3296100

    (State or other jurisdiction

    of incorporation)

     

    (Commission

    File Number)

     

    (I.R.S. Employer

    Identification No.)

     

    4800 Montgomery Lane, Suite 210

    Bethesda, MD

      20814
    (Address of Principal Executive Offices)   (Zip Code)

     

    Registrant’s telephone number, including area code: (301) 971-3955

     

    N/A

    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐ Written communications pursuant to Rule 425 under the Securities Act
       
    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act
       
    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
       
    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered
    Units, each consisting of one share of Class A Common Stock, one-half of one Redeemable Warrant and one Right   ACAXU   The Nasdaq Global Market
    Class A Common Stock, par value $0.0001 per share   ACAX   The Nasdaq Global Market
    Redeemable warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share   ACAXW   The Nasdaq Global Market
    Rights, each entitling the holder to receive one-tenth of one share of Class A Common Stock   ACAXR   The Nasdaq Global Market

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

     

    Emerging growth company ☒

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

     

     

     

    Item 8.01 Other Events.

     

    Alset Capital Acquisition Corp. (“Alset”) is providing the following updates regarding the opportunity for stockholders to redeem Class A Common Stock.

     

    Alset has extended the deadline for stockholders to redeem Class A Common Stock until 5:00 p.m. Eastern Time on Friday, November 3, 2023 (“the Revised Deadline”). The Revised Deadline shall apply to any shares of Class A Common Stock being redeemed in connection with either the August 1, 2023 Special Meeting of Stockholders or the planned November 2, 2023 Special Meeting of Stockholders. Stockholders may submit redemption requests in connection with either of these meetings. Any future extension of the Revised Deadline would apply to both groups, and Alset has increased the redemption amount per share for stockholders to redeem Class A Common Stock from $10.50 to $10.60 for both groups.

     

    As previously disclosed, Alset and the other parties to its Merger Agreement are working towards satisfaction of the conditions to completion of the Proposed Business Combination approved by stockholders at the August 1, 2023 Special Meeting of Stockholders. The Company is waiting for the approval by the Nasdaq of the initial listing application of HWH International Inc. There can be no assurance that such approval will be obtained.

     

    The closing of Alset’s planned business combination will not occur until after the Revised Deadline, as the same may be extended. Accordingly, stockholders will be permitted to redeem shares of Class A Common Stock prior to any closing of the Proposed Business Combination.

     

    Stockholders are encouraged to please see the Definitive Proxy Statement for the November 2, 2023 Special Meeting of Stockholders.  We encourage all Stockholders to please cast their vote in connection with such Special Meeting.

     

    In addition, stockholders who previously submitted redemption requests may withdraw such previously submitted redemption requests until the Revised Deadline of 5:00 p.m. Eastern Time on Friday, November 3, 2023.

     

    If you have not already done so, in order to exercise your redemption rights, you must, prior to the Revised Deadline of 5:00 p.m. Eastern Time on Friday, November 3, 2023, tender your shares physically or electronically and submit a request in writing that we redeem your public shares for cash to VStock Transfer LLC, our transfer agent, at the following address:

     

    VStock Transfer LLC

    18 Lafayette Place

    Woodmere, NY 11598

    Attn: DWAC Team

    E-mail: [email protected]

     

    Stockholders who wish to withdraw their previously submitted redemption requests may do so by contacting Alset’s transfer agent VStock Transfer, LLC at Attn: DWAC team, Email: [email protected] prior to the Revised Deadline.

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Dated: October 31, 2023

     

    ALSET CAPITAL ACQUISITION CORP.  
       
    By: /s/ Rongguo Wei  
    Name: Rongguo Wei  
    Title: Chief Financial Officer  

     

     

    Get the next $ACAX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACAX

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ACAX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chan Heng Fai Ambrose disposed of 347,220 shares (SEC Form 4)

    4 - HWH International Inc. (0001897245) (Issuer)

    2/1/24 9:45:27 PM ET
    $ACAX
    Other Pharmaceuticals
    Health Care

    New insider Alset Inc. claimed ownership of 13,577,375 shares (SEC Form 3)

    3 - HWH International Inc. (0001897245) (Issuer)

    1/19/24 7:57:05 PM ET
    $ACAX
    Other Pharmaceuticals
    Health Care

    SEC Form 3 filed by new insider Chan Anthony S.

    3 - HWH International Inc. (0001897245) (Issuer)

    1/17/24 6:03:45 PM ET
    $ACAX
    Other Pharmaceuticals
    Health Care

    $ACAX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $ACAX
    SEC Filings

    View All

    SEC Form 4 filed by Wolverine Asset Management Llc

    4 - HWH International Inc. (0001897245) (Issuer)

    1/12/24 12:04:38 PM ET
    $ACAX
    Other Pharmaceuticals
    Health Care

    SEC Form 8-K filed by Alset Capital Acquisition Corp.

    8-K - HWH International Inc. (0001897245) (Filer)

    2/12/24 9:00:29 AM ET
    $ACAX
    Other Pharmaceuticals
    Health Care

    Alset Capital Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Change in Shell Company Status, Financial Statements and Exhibits, Leadership Update, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

    8-K - HWH International Inc. (0001897245) (Filer)

    1/12/24 5:22:46 PM ET
    $ACAX
    Other Pharmaceuticals
    Health Care

    SEC Form 25-NSE filed by Alset Capital Acquisition Corp.

    25-NSE - Alset Capital Acquisition Corp. (0001897245) (Subject)

    1/8/24 5:03:55 PM ET
    $ACAX
    Other Pharmaceuticals
    Health Care

    $ACAX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    HWH International together with Alset Capital Acquisition Corp. Announce Closing of Business Combination

    The common stock of the combined company is expected to commence trading on The Nasdaq Global Market under ticker symbol "HWH" on January 9, 2024. Bethesda, MD, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Alset Capital Acquisition Corp. ("Alset") (Nasdaq: "ACAX" for common stock and "ACAXR" for rights), today announced the completion of its previously announced business combination (the "Business Combination"), with HWH International Inc. ("HWH"), a purpose-driven lifestyle company encompassing differentiated offerings from four core pillars: HWH Marketplace, Hapi Cafe, Hapi Travel Destination and Hapi Wealth Builder. The common stock of the combined company is expected to begin trading on The Nasd

    1/8/24 12:20:00 PM ET
    $ACAX
    Other Pharmaceuticals
    Health Care

    Alset Capital Acquisition Corp. Provides Additional Update Regarding Stockholder Redemptions

    Bethesda, MD, Aug. 23, 2023 (GLOBE NEWSWIRE) -- Alset Capital Acquisition Corp. (NASDAQ:ACAX) ("Alset") provided additional updates today regarding stockholder redemptions. Alset currently has 1,911,236 shares of publicly held Class A common stock issued, outstanding and held by non-affiliates (such number of shares does not include any shares of Class A common stock held by Alset's Sponsor and management). Alset has extended the deadline for stockholders to redeem Class A common stock until 5:00 p.m. Eastern Time on Wednesday, September 13, 2023 ("the Revised Deadline"). In addition, stockholders who previously submitted redemption requests may withdraw such previously submitted redemp

    8/23/23 10:52:00 AM ET
    $ACAX
    Other Pharmaceuticals
    Health Care

    Alset Capital Acquisition Corp. Provides Additional Update Regarding Stockholder Redemptions

    Bethesda, MD, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Alset Capital Acquisition Corp. (NASDAQ:ACAX) ("Alset") provided additional updates today regarding stockholder redemptions. Alset will be accepting requests by any public stockholder who submitted a request to redeem their Class A common stock prior to the deadline of July 28, 2023 to withdraw such previously submitted redemption requests until 5:00 p.m. Eastern Time on Wednesday, August 23, 2023. Stockholders who wish to withdraw their previously submitted redemption requests may do so by contacting Alset's transfer agent VStock Transfer, LLC at Attn: DWAC team, Email: [email protected]. About Alset Capital Acquisition Corp. Alset

    8/14/23 12:55:00 PM ET
    $ACAX
    Other Pharmaceuticals
    Health Care

    $ACAX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Alset Capital Acquisition Corp.

    SC 13G - HWH International Inc. (0001897245) (Subject)

    2/14/24 4:59:56 PM ET
    $ACAX
    Other Pharmaceuticals
    Health Care

    SEC Form SC 13G/A filed by Alset Capital Acquisition Corp. (Amendment)

    SC 13G/A - HWH International Inc. (0001897245) (Subject)

    2/14/24 3:30:10 PM ET
    $ACAX
    Other Pharmaceuticals
    Health Care

    SEC Form SC 13G/A filed by Alset Capital Acquisition Corp. (Amendment)

    SC 13G/A - HWH International Inc. (0001897245) (Subject)

    2/14/24 12:26:24 PM ET
    $ACAX
    Other Pharmaceuticals
    Health Care